Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details Narrative)

v3.7.0.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Jan. 02, 2017
Dec. 31, 2016
Research and development $ 122,300 $ 309,429    
Total dilutive shares        
Common stock shares issued 48,422,386   48,422,386     29,684,191
Common stock shares outstanding 48,422,386   48,422,386     29,684,191
Accumulated deficit $ (8,402,873)   $ (8,402,873)   $ 388,667 $ (6,863,102)
Restatement Adjustment [Member]            
Common stock shares issued           32,760
Common stock shares outstanding           32,760
Scenario, Previously Reported [Member]            
Common stock shares issued           29,651,431
Common stock shares outstanding           29,651,431
Common Stock Options [Member]            
Antidilutive securities excluded from computation of net loss per share, amount     6,915,480 5,165,480    
Common Stock Warrants [Member]            
Antidilutive securities excluded from computation of net loss per share, amount     3,568,845 1,568,845    
Conversion of Debentures [Member]            
Antidilutive securities excluded from computation of net loss per share, amount     1,100,000 1,584,524    
Conversion of Notes Payable [Member]            
Antidilutive securities excluded from computation of net loss per share, amount     5,000,000      
Conversion of Redeemable Convertible Preferred Stock [Member]            
Antidilutive securities excluded from computation of net loss per share, amount     4,000,000 2,857,142